2. Update on primary immunodeficiency diseases

https://doi.org/10.1016/j.jaci.2005.09.051Get rights and content

The pace of discovery in primary immunodeficiency continues to accelerate. In particular, lymphocyte defects have been the source of the most impressive expansion in recent years. Novel forms of agammaglobulinemia, class-switch defects, and T-B+ severe combined immunodeficiency have been described. Little by little, the genetic heterogeneity of the common variable immunodeficiency and IgA deficiency phenotypes continues to be unraveled as new molecular defects have been reported in these patients as well. The phenotypic spectrum of DiGeorge syndrome has been further developed, along with promising advances in therapy. Defects of nuclear factor κB regulation and Toll-like receptor signaling have been described, along with defects of chemokine receptors and cytoplasmic proteases. Clinically defined immunodeficiencies, such as hyper-IgE syndrome and idiopathic CD4 lymphocytopenia, are also discussed. Finally, significant adverse effects in some patients have tempered initial enthusiasm for gene therapy.

Section snippets

Antibody deficiencies

A form of agammaglobulinemia with absent B cells in a girl with abnormal facies has been ascribed to alteration of the leucine-rich repeat–containing 8 gene (LRRC8).3 LRRC8 belongs to a family of leucine-rich proteins of unknown function.4 In the single patient described, a balanced chromosomal translocation permitted expression of a truncated molecule that exhibited dominant negative activity. B-cell development was arrested in the bone marrow, as in other forms of agammaglobulinemia.5

Cellular deficiencies

Idiopathic CD4 lymphocytopenia is a rare immunodeficiency of unknown cause that clinically closely resembles HIV infection, but the absence of this and related viruses by means of all serologic and molecular methods of detection is a crucial element of the case definition.20 Patients have persistently low CD4 T-cell counts (<300 cells/mm3) and experience opportunistic infections, autoimmune disease, and hematologic malignancies.

As yet poorly characterized isolated defects of natural killer (NK)

Combined deficiencies

A novel form of TB+NK+ SCID has been described in association with defects of the CD3δ chain (CD3D mutation).24 The CD3 complex transduces signals initiated by interaction of the T-cell receptor with an MHC-peptide complex. Defects of other components of the CD3 complex (γ and ɛ chains) and associated kinases (ζ-associated protein, 70 kd) have been associated with SCID or deficient cellular immunity.1, 2 Interestingly, SCID caused by a CD3δ defect might be distinct from others in that a thymus

Phagocyte defects

It is now clear that both cyclic neutropenia and a subset of Kostmann's syndrome, or congenital agranulocytosis, can result from deficiency of elastase 2.45 Mutations in the granulocyte colony-stimulating factor receptor (CSF3R gene) that had previously been identified in patients with Kostmann's syndrome were found to have been acquired, possibly because of an underlying genetic instability in this disorder. Note that X-linked neutropenia has been associated with particular mutations of the

Therapy of immunodeficiency

Two forms of SCID have been treated successfully with gene therapy: X-linked SCID (IL2RG mutation) and adenosine deaminase deficiency.49, 50 Approximately 20 patients in France, the United Kingdom, and the United States have been treated this way. Unfortunately, leukemia has developed in 3 patients thus far, apparently because of integration of the vector in a sensitive site for regulation of cell division (the LMO2 gene).51 For this reason, gene therapy trials are currently under review.

References (51)

  • J.S. Orange

    Human natural killer cell deficiencies and susceptibility to infection

    Microbes Infect

    (2002)
  • M. Vitale et al.

    Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells

    Blood

    (2002)
  • T. Yabe et al.

    A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombination

    Blood

    (2002)
  • H. Yagi et al.

    Role of TBX1 in human del22q11.2 syndrome

    Lancet

    (2003)
  • M.L. Markert et al.

    Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients

    Blood

    (2003)
  • J. Chinen et al.

    Long-term assessment of T-cell populations in DiGeorge syndrome

    J Allergy Clin Immunol

    (2003)
  • E.H. Moylett et al.

    Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity

    Clin Immunol

    (2004)
  • M.L. Markert et al.

    Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome

    Blood

    (2004)
  • M. Ege et al.

    Omenn syndrome due to ARTEMIS mutations

    Blood

    (2005)
  • J.S. Orange et al.

    Human nuclear factor κB essential modulator mutation can result in immunodeficiency without ectodermal dysplasia

    J Allergy Clin Immunol

    (2004)
  • T. Niehues et al.

    Nuclear factor κB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia

    J Allergy Clin Immunol

    (2004)
  • Z.B. Wang et al.

    Pathways to caspase activation

    Cell Biol Int

    (2005)
  • C. Zeidler et al.

    Kostmann syndrome and severe congenital neutropenia

    Semin Hematol

    (2002)
  • E.D. Renner et al.

    Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity

    J Pediatr

    (2004)
  • H.B. Gaspar et al.

    Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

    Lancet

    (2004)
  • Cited by (45)

    • Evaluation of the frequency and diagnostic delay of primary immunodeficiency disorders among suspected patients based on the 10 warning sign criteria: A cross-sectional study in Iran

      2020, Allergologia et Immunopathologia
      Citation Excerpt :

      Bacillus Calmette-Guérin vaccination is routinely administered to infants in Iran within the first month of life, usually at birth. BCGitis is a complication we might see in non-PID patients but along with other infections one should doubt if there is an underlying cause.33 The third patient with SCID was a four-month-old girl diagnosed with cytomegalovirus (CMV) pneumonia.

    • Immunologic Development and Susceptibility to Infection

      2018, Principles and Practice of Pediatric Infectious Diseases
    • Pulmonary Complications of Primary Immunodeficiencies

      2015, Murray and Nadel's Textbook of Respiratory Medicine: Volume 1,2, Sixth Edition
    • Immunologic Development and Susceptibility to Infection

      2012, Principles and Practice of Pediatric Infectious Diseases, Fourth Edition
    • Approach to the Child with Recurrent Infections

      2010, Pediatric Allergy: Principles and Practice Expert Consult: Second Edition
    View all citing articles on Scopus
    View full text